SOURCE: CISION PR Newswire
CDI Labs' Monoclonal Antibody Development Pipeline featured in Nature MethodsProteomics company leverages microarray capability to develop truly monospecific monoclonal antibodies
READ MORESOURCE: BioSpace
CDI Labs Collaborates on Discovery of New Biomarkers for Zika Infection READ MORESOURCE: CISION PR Newswire
CDI Labs Cites New Research Identifying Early Lung Cancer Autoantibody Biomarkers using HuProt™Proteomics company's high-content proteome microarray gaining traction in disease diagnosis and prognosis.
READ MORESOURCE: Technology Networks - Proteomics and Metabolomics
The World's Largest Human Proteome Microarray: Advancing Protein Biomarker DiscoveryAdvancing Protein Biomarker Discovery
READ MORESOURCE: CISION PR Newswire
CDI Labs Expands HuProt™ - The Highest Content Human Proteome Microarray in the WorldProteomics company now producing glass slides printed with recombinant human proteins comprising 81% of the human proteome for high throughput analytics, contract research and hybridoma development services.
READ MORESOURCE: CISION PR Newswire
CDI Laboratories and NeoBiotechnologies Form Alliance to Distribute CDI's 2500 Monospecific Transcription Factor Antibodies READ MORE2